Literature DB >> 12399058

Does bone change after biliopancreatic diversion?

Picard Marceau1, Simon Biron, Stéfane Lebel, Simon Marceau, Frédéric S Hould, Serge Simard, Marcel Dumont, Lorraine A Fitzpatrick.   

Abstract

This prospective study evaluated bone changes after biliopancreatic diversion (BPD) consisting of a distal gastrectomy, a 250 cm alimentary channel, and a 50 cm common channel. Thirty-three consecutive patients had clinical, biochemical, and bone mineral density analysis before surgery and 4 and 10 years after surgery. Iliac crest bone biopsies and special tests including parathyroid hormone (PTH), 25-hydroxyvitamin D (25-OH-D), 1,25-dihydroxyvitamin D (1,25-OH(2)-D), bone-specific alkaline phosphatase (BAP), and osteocalcin were obtained at surgery and 4 years postoperatively. Over the years, with close metabolic surveillance, additional calcium and vitamin D were given as indicated. After BPD, serum levels of calcium and vitamin D were decreased and serum levels of PTH, BAP, and osteocalcin were increased. Bone turnover and mineralization were both increased. Mean osteoid volume (P < 0.0007) and bone formation rate in relation to bone volume (P < 0.02) were increased. Static measures of bone were altered as follows: cortical thickness decreased (P < 0.01) and trabecular bone volume increased (P < 0.01). Ten years after surgery, overall bone mineral density was unchanged at the hip and was decreased by 4% at the lumbar spine. Overall fracture risk, based on the Z score, was unchanged. Preoperative factors predicting bone loss included menopause, smoking, and preexisting osteopenia. An elevated level of 1,25-OH(2)-D was also found to be a predictor of future bone loss (r = 0.40; P < 0.002). After surgery, a greater increase in bone markers and bone turnover was associated with an increased risk of bone loss. Although elevated osteocalcin levels were associated with overall bone loss (r = 0.52; P < 0.002), lower albumin levels were associated only with bone loss at hip level (r = 0.44; P < 0.02), whereas lower calcium levels were associated only with the loss at the lumbar spine (r = 0.39; P < 0.02). Ten years after surgery, bone loss at the hip continued to depend on albumin levels (r = 0.37; P < 0.03). We concluded that bone was relatively tolerant to the metabolic changes due to BPD. Provided that there is close surveillance for metabolic disturbances, the use of appropriate supplements, and the avoidance of malnutrition, the beneficial effects of surgery far outweigh the risk of postoperative bone disease. Copyright 2002 The Society for Surgery of the Alimentary Tract, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399058     DOI: 10.1016/s1091-255x(01)00086-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

Review 1.  Clinical use of bone densitometry.

Authors:  C C Johnston; C W Slemenda; L J Melton
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

2.  Single-dose tetracycline labeling for bone histomorphometry.

Authors:  D J Sherrard; N A Maloney
Journal:  Am J Clin Pathol       Date:  1989-06       Impact factor: 2.493

3.  Calcium absorption and bone mineral contents following intestinal shunt operation in obesity.

Authors:  P Danö; C Christiansen
Journal:  Scand J Gastroenterol       Date:  1974-11       Impact factor: 2.423

4.  Effects of vertical-banded gastroplasty on bone and mineral metabolism in obese patients.

Authors:  T Cundy; M C Evans; R G Kay; M Dowman; D Wattie; I R Reid
Journal:  Br J Surg       Date:  1996-10       Impact factor: 6.939

5.  Biochemical Evidence of Metabolic Bone Disease in Women Following Roux-Y Gastric Bypass for Morbid Obesity.

Authors: 
Journal:  Obes Surg       Date:  1992-11       Impact factor: 4.129

6.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

Review 7.  Jejunoileal bypass for morbid obesity. A critical appraisal.

Authors:  J D Halverson; L Wise; M F Wazna; W F Ballinger
Journal:  Am J Med       Date:  1978-03       Impact factor: 4.965

8.  Impairment of vitamin D metabolism and bone mineral content after intestinal bypass for obesity. A longitudinal study.

Authors:  H Rickers; C Christiansen; I Balslev; P Rødbro
Journal:  Scand J Gastroenterol       Date:  1984-03       Impact factor: 2.423

9.  Evidence for alteration of the vitamin D-endocrine system in obese subjects.

Authors:  N H Bell; S Epstein; A Greene; J Shary; M J Oexmann; S Shaw
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

10.  Calcium malabsorption and absence of bone decalcination following intestinal shunt operation for obesity. A comparison of two types of operation.

Authors:  P Danö; C Christiansen
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

View more
  31 in total

Review 1.  Examining the link between bariatric surgery, bone loss, and osteoporosis: a review of bone density studies.

Authors:  Lesley M Scibora; Sayeed Ikramuddin; Henry Buchwald; Moira A Petit
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

2.  High dose vitamin D supplementation does not rescue bone loss following Roux-en-Y gastric bypass in female rats.

Authors:  Aidi Niu; Thomas O Carpenter; Jayleen M Grams; Shahab Bozorgmehri; Steven M Tommasini; Anne L Schafer; Benjamin K Canales
Journal:  Bone       Date:  2019-06-19       Impact factor: 4.398

Review 3.  Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers.

Authors:  Hélène Wucher; Cécile Ciangura; Christine Poitou; Sébastien Czernichow
Journal:  Obes Surg       Date:  2007-12-11       Impact factor: 4.129

Review 4.  Nutritional deficiencies after bariatric surgery.

Authors:  D J Davies; J M Baxter; J N Baxter
Journal:  Obes Surg       Date:  2007-09       Impact factor: 4.129

Review 5.  Bone Health following Bariatric Surgery: Implications for Management Strategies to Attenuate Bone Loss.

Authors:  Tair Ben-Porat; Ram Elazary; Shiri Sherf-Dagan; Ariela Goldenshluger; Ronit Brodie; Yoav Mintz; Ram Weiss
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

6.  Bone mass decreases in morbidly obese women after long limb-biliopancreatic diversion and marked weight loss without secondary hyperparathyroidism. A physiological adaptation to weight loss?

Authors:  Dimitrios D A Tsiftsis; Panagiotis Mylonas; Nancy Mead; Fotis Kalfarentzos; Theodore K Alexandrides
Journal:  Obes Surg       Date:  2009-08-29       Impact factor: 4.129

7.  Bariatric surgery: To bypass or switch? That is the question in obesity surgery.

Authors:  Michel Gagner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-04-14       Impact factor: 46.802

8.  Long-Term Metabolic Outcomes 5 to 20 Years After Biliopancreatic Diversion.

Authors:  Picard Marceau; Simon Biron; Simon Marceau; Frederic-Simon Hould; Stefane Lebel; Odette Lescelleur; Laurent Biertho; Serge Simard; John G Kral
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

Review 9.  Bone Health After Bariatric Surgery.

Authors:  Claudia Gagnon; Anne L Schafer
Journal:  JBMR Plus       Date:  2018-05-01

10.  Laparoscopic adjustable pyloric band with fundoplication in bariatric surgery: technique and preliminary results.

Authors:  Jacques Himpens
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.